Cardiovascular risk management: applying the latest insights to clinical care in Russia
PACE review based on the Cardiovascular Risk Master Class -Moscow, Russia (Oct 2016). Written by: Brouwer JR and Susekov A.Download a free copy of this review on CV risk management in Russia.
Scroll down to download a free copy
In Moscow on October 14-15, 2016, physicians and experts gathered for a Cardiovascular Risk Master Class, to learn and update how the latest scientific insights can be applied to clinical care. The recent data on the pathophysiology of coronary artery disease and stroke were discussed, including how intensive treatment of dyslipidaemia and hypertension can prevent cardiovascular events in high-risk populations.
This Master Class aimed to provide a platform for the review, exchange and assimilation and implementation of important data and ideas, in order to accelerate the translation of the latest insights in to clinical practice in Russia. By considering Russian epidemiology and guidelines on diagnosis and treatment, it can be concluded where management of Russian patients could improve. This document captures the essentials of what was discussed and what is to be implemented in routine clinical practice in Russia.
The overall educational objectives of the Cardiovascular Master Class were to:
- review the epidemiology and current guidelines on the diagnosis, management, and treatment of patients at increased CV risk in Russia
- review new data on the pathophysiology of coronary artery disease and stroke and its relevance to treatment strategies and outcomes
- understand the medical need for intensive lipid and hypertension management in patients at high CV risk, such as DM and metabolic syndrome.
- understand the pharmacologic and clinical rationale for various treatment options in the patients with increased CV risk and integrate scientific evidence from key clinical trials into clinical practice
- Develop a consensus on practical guidelines for day-to-day management of high risk patients
This activity has been planned and implemented in accordance with the accreditation requirements and policies of Russian Ministry of Health (Order # 82 from 18.02.2013) through the providership of Russian Cardiology Society and Russian CME Botkin Society is accredited by the the Coordination Council for Continuing Medical and Pharmaceutical to provide continuing medical education for physicians, granting 9 credits
The conference was sponsored by an unrestricted educational grant provided by Pfizer Europe.